Association between wind-up ratio and central serotonergic function in healthy subjects and depressed patients

Neuroscience Letters

Volumn 504, Issue 2, 2011, Pages 176-180

  Uhl, Idun ^a   Krumova, Elena K ^b   Regeniter, Sabrina ^a   Bär, Karl Jürgen ^a   Norra, Christine ^a   Richter, Helmut ^b   Assion, Hans Jörg ^a   Westermann, Andrea ^b   Juckel, Georg ^a   Maier, Christoph ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Depression; Intensity dependence; Pain; Quantitative sensory testing; Serotonin; Wind up

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LOUDNESS; MAJOR DEPRESSION; MALE; NOCICEPTIVE STIMULATION; PAIN; PRIORITY JOURNAL; PSYCHOMETRY; QUANTITATIVE SENSORY TESTING; SENSORY SYSTEM EXAMINATION; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; STIMULUS RESPONSE; TEMPORAL SUMMATION; WIND UP RATIO;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; NERVE FIBERS, UNMYELINATED; PAIN; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 80053949334     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.033     Document Type: Article

References (47)

1. Afra J. Intensity dependence of auditory evoked cortical potentials in migraine. Changes in the peri-ictal period. Funct. Neurol. 2005, 20:199-200.
2. Attal N., Cruccu G., Baron R., Haanpää M., Hansson P., Jensen T.S., Nurmikko T. European Federation of Neurological Societies, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 2010, 17:1113-1188.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
4. Carrillo-de-la-Peña M.T., Vallet M., Pérez M.I., Gómez-Perretta C. Intensity dependence of auditory-evoked cortical potentials in fibromyalgia patients: a test of the generalized hypervigilance hypothesis. J. Pain 2006, 7:480-487.
5. Edvinsson L., Uddman R. Neurobiology in primary headaches. Brain Res. Brain Res. Rev. 2005, 48:438-456.
6. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatric Press Inc., Washington, DC.
7. Fitzgerald P.B., Mellow T.B., Hoy K.E., Segrave R., Cooper N.R., Upton D.J., Croft R.J. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. J. Affect. Disord. 2009, 117:212-216.
8. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., Mavrogiorgou P., Hegerl U. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl.) 2000, 148:404-411.
9. Gallinat J., Kunz D., Lang U.E., Kalus P., Juckel G., Eggers J., Mahlberg R., Staedtgen M., Wernicke C., Rommelspacher H., Smolka M.N. Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing. Pharmacopsychiatry 2005, 38:158-160.
10. Giesecke T., Gracely R.H., Williams D.A., Geisser M.E., Petzke F.W., Clauw D.J. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005, 52:1577-1584.
11. Gracely R.H., Geisser M.E., Giesecke T., Grant M.A., Petzke F., Williams D.A., Clauw D.J. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004, 127:835-843.
12. Guille V., Croft R.J., O'Neill B.V., Illic S., Phan K.L., Nathan P.J. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum. Psychopharmacol. 2008, 23:231-241.
13. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
14. Hegerl U., Juckel G., Möller H.J. Event related brain potentials as indicators of neurochemical dysfunctions in psychiatric patients. Nervenarzt 1996, 67:360-368.
15. Hensch T., Herold U., Diers K., Armbruster D., Brocke B. Reliability of intensity dependence of auditory-evoked potentials. Clin. Neurophysiol. 2008, 119:224-236.
16. Herrero J.F., Laird J.M., Lopez-Garcia J.A. Wind-up of spinal cord neurones and pain sensation: much ado about something?. Prog. Neurobiol. 2000, 61:169-203.
17. Jans L.A., Riedel W.J., Markus C.R., Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol. Psychiatry 2007, 12:522-543.
18. Jeong C.Y., Choi J.I., Yoon M.H. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur. J. Pharmacol. 2004, 502:205-211.
19. Juckel G., Molnár M., Hegerl U., Csépe V., Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity-first evidence in behaving cats. Biol. Psychiatry 1997, 41:1181-1195.
20. Juckel G., Gallinat J., Riedel M., Sokullu S., Schulz C., Möller H.J., Müller N., Hegerl U. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr. Res. 2003, 64:115-124.
21. Juckel G., Pogarell O., Augustin H., Mulert C., Müller-Siecheneder F., Frodl T., Mavrogiorgou P., Hegerl U. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J. Clin. Psychiatry 2007, 68:1206-1212.
22. Juckel G., Gudlowski Y., Müller D., Özgürdal S., Brüne M., Gallinat J., Frodl T., Witthaus H., Uhl I., Wutzler A., Pogarell O., Mulert C., Hegerl U., Meisenzahl E.M. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia-a replication study. Psychiatry Res. 2008, 158:79-82.
23. Klauenberg S., Maier C., Assion H.J., Hoffmann A., Krumova E.K., Magerl W., Scherens A., Treede R.D., Juckel G. Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 2008, 140:332-343.
24. Kundermann B., Hemmeter-Spernal J., Strate P., Gebhardt S., Huber M.T., Krieg J.C., Lautenbacher S. Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine. J. Psychiatr. Res. 2009, 43:1253-1261.
25. Li J., Simone D.A., Larson A.A. Windup leads to characteristics of central sensitization. Pain 1999, 79:75-82.
26. Linka T., Sartory G., Bender S., Gastpar M., Müller B.W. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls, an analysis of group differences. J. Affect. Disord. 2007, 103:139-145.
27. Magerl W., Krumova E.K., Baron R., Tölle T., Treede R.D., Maier C. Technical note: reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 2010, 151:598-605.
28. Maier C., Baron R., Tölle T.R., Binder A., Birbaumer N., Birklein F., Gierthmühlen J., Flor H., Geber C., Huge V., Krumova E.K., Landwehrmeyer G.B., Magerl W., Maihöfner C., Richter H., Rolke R., Scherens A., Schwarz A., Sommer C., Tronnier V., Üçeyler N., Valet M., Wasner G., Treede R.D. Quantitative Sensory Testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010, 150:439-450.
29. Manjarrez-Gutierrez G., Marquez R.H., Mejenes-Alvarez S.A., Godinez-Lopez T., Hernandez-R J. Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression. World J. Biol. Psychiatry 2009, 10:877-883.
30. Marks D.M., Shah M.J., Patkar A.A., Masand P.S., Park G.Y., Pae C.U. Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr. Neuropharmacol. 2009, 7:331-336.
31. Mason P. Deconstructing endogenous pain modulations. J. Neurophysiol. 2005, 94:1659-1663.
32. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
33. Ninan P.T., van Kammen D.P., Scheinin M., Linnoila M., Bunney W.E., Goodwin F.K. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am. J. Psychiatry 1984, 141:566-569.
34. Norra C., Mrazek M., Tuchtenhagen F., Gobbelé R., Buchner H., Sass H., Herpertz S.C. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J. Psychiatr. Res. 2003, 37:23-33.
35. O'Neill B.V., Croft R.J., Leung S., Oliver C., Phan K.L., Nathan P.J. High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacology (Berl.) 2007, 195:85-93.
36. O'Neill B.V., Guille V., Croft R.J., Leung S., Scholes K.E., Phan K.L., Nathan P.J. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum. Psychopharmacol. 2008, 23:301-312.
37. Park Y.M., Lee S.H., Kim S., Bae S.M. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:313-316.
38. Proietti-Cecchini A., Afra J., Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia 1997, 17:849-854.
39. Rolke R., Baron R., Maier C., Tölle T.R., Treede R.D., Beyer A., Binder A., Birbaumer N., Birklein F., Botefur I.C., Braune S., Flor H., Huge V., Klug R., Landwehrmeyer G.B., Magerl W., Maihofner C., Rolko C., Schaub C., Scherens A., Sprenger T., Valet M., Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006, 123:231-243.
40. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999, 83:389-400.
41. Sommer C. Is serotonin hyperalgesic or analgesic?. Curr. Pain Headache Rep. 2006, 10:101-106.
42. Suzuki T., Tygh L.J., Dickenson A.H. Bad news from the brain: descending 5-HT-pathways that control spinal pain processing. Trends Pharmacol. Sci. 2004, 25:613-617.
43. Vase L., Nikolajsen L., Christensen B., Lindhart Egsgaard L., Arendt-Nielsen L., Svensson P., Staehelin Jensen T. Cognitive-emotional sensitization contributes to wind-up-like pain in phantom limb pain patients. Pain 2011, 152:157-162.
44. Woolf C.J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011, 152(3 Suppl.):S2-S15.
45. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
46. Wutzler A., Winter C., Kitzrow W., Uhl I., Wolf R.J., Heinz A., Juckel G. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 2008, 33:3176-3181.
47. Yaksh T.L., Tyce G.M. Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cord. Brain Res. 1979, 171:176-181.